338 related articles for article (PubMed ID: 10970952)
21. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.
Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA
J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310
[TBL] [Abstract][Full Text] [Related]
22. New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist.
McGrath GA; Goncalves RJ; Udupa JK; Grossman RI; Pavlou SN; Molitch ME; Rivier J; Vale WW; Snyder PJ
J Clin Endocrinol Metab; 1993 May; 76(5):1363-8. PubMed ID: 8496331
[TBL] [Abstract][Full Text] [Related]
23. Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
Daniels M; Newland P; Dunn J; Kendall-Taylor P; White MC
J Endocrinol; 1988 Sep; 118(3):491-6. PubMed ID: 2460576
[TBL] [Abstract][Full Text] [Related]
24. Hypersecretion of LH and FSH by a pituitary adenoma.
Snyder PJ; Sterling FH
J Clin Endocrinol Metab; 1976 Mar; 42(3):544-50. PubMed ID: 767353
[TBL] [Abstract][Full Text] [Related]
25. A clinically functioning gonadotroph adenoma presenting with abdominal pain, ovarian hyperstimulation and fibromatosis.
Broughton C; Mears J; Williams A; Lonnen K
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30532999
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
Blanco C; Lucas T; Alcañiz J; Davila N; Serrano P; Barcelò B; Estrada J
J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
[TBL] [Abstract][Full Text] [Related]
27. Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas.
Caretto A; Lanzi R; Piani C; Molgora M; Mortini P; Losa M
Pituitary; 2017 Oct; 20(5):553-560. PubMed ID: 28676954
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion.
Snyder PJ; Muzyka R; Johnson J; Utiger RD
J Clin Endocrinol Metab; 1980 Oct; 51(4):744-8. PubMed ID: 6774992
[TBL] [Abstract][Full Text] [Related]
29. [Clinically non functioning pituitary adenomas and gonadotroph-cell adenomas].
Caron P
Presse Med; 2009 Jan; 38(1):103-6. PubMed ID: 18990542
[TBL] [Abstract][Full Text] [Related]
30. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.
Harris RI; Schatz NJ; Gennarelli T; Savino PJ; Cobbs WH; Snyder PJ
J Clin Endocrinol Metab; 1983 Jun; 56(6):1288-93. PubMed ID: 6404924
[TBL] [Abstract][Full Text] [Related]
31. [Gonadotroph adenomas].
Takada K; Yamada S; Teramoto A
Nihon Rinsho; 1993 Oct; 51(10):2691-5. PubMed ID: 8254941
[TBL] [Abstract][Full Text] [Related]
32. Gonadotroph adenoma causing ovarian hyperstimulation syndrome in a premenopausal woman.
Halupczok J; Bidzińska-Speichert B; Lenarcik-Kabza A; Zieliński G; Filus A; Maksymowicz M
Gynecol Endocrinol; 2014 Nov; 30(11):774-7. PubMed ID: 24971660
[TBL] [Abstract][Full Text] [Related]
33. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
35. Double adenoma of the pituitary: a somatotroph adenoma colliding with a gonadotroph adenoma.
Syro LV; Horvath E; Kovacs K
J Endocrinol Invest; 2000 Jan; 23(1):37-41. PubMed ID: 10698050
[TBL] [Abstract][Full Text] [Related]
36. Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men.
Lahlou N; Le Nestour E; Chanson P; Seret-Bégué D; Bouchard P; Roger M; Warnet A
Clin Endocrinol (Oxf); 1993 Mar; 38(3):301-9. PubMed ID: 8458102
[TBL] [Abstract][Full Text] [Related]
37. Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma.
Shimon I; Rubinek T; Bar-Hava I; Nass D; Hadani M; Amsterdam A; Harel G
J Clin Endocrinol Metab; 2001 Aug; 86(8):3635-40. PubMed ID: 11502789
[TBL] [Abstract][Full Text] [Related]
38. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
[TBL] [Abstract][Full Text] [Related]
39. [Gonadotropic adenomas].
Waterlot C; Cortet-Rudelli C; Fossati P; Dewailly D
Rev Prat; 1996 Jun; 46(12):1498-1503. PubMed ID: 8881164
[TBL] [Abstract][Full Text] [Related]
40. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas.
Snyder PJ; Bashey HM; Kim SU; Chappel SC
J Clin Endocrinol Metab; 1984 Dec; 59(6):1169-75. PubMed ID: 6436288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
